Global Interferons Market Outlook, 2019-2023 - The Advent of Novel Drug Delivery & Combination Therapies is Driving Growth - ResearchAndMarkets.com

The "Global Interferons Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The interferons market will register a CAGR of almost 2% by 2023.

Interferons belong to the family of cytokines, a group of small proteins essential in cell signaling. They are synthesized and delivered by host cells in response to a pathogen's harmful activities. They are generally used for treating immune system-related diseases such as cancer, hepatitis, ADS, multiple sclerosis, genital and perianal warts, and granulomatous disease.

Since these therapeutics directly work on the target, they demonstrate higher efficacy than conventional treatments. Therefore, the versatility of this therapeutic class makes it one of the preferred treatment choices by medical practitioners, as well as patients, thereby driving market growth. Interferons have high target affinity, which is expected to increase their demand, thereby driving market growth.

Advent of novel drug delivery and combination therapies

Considering their biological nature, interferons are mostly administered through the intravenous RoA due to which they are associated with side effects such as redness, irritation, and swelling at the injection site. Thus, they can significantly improve patient compliance and help in better management of hepatitis B.

High cost associated with treatment

Treatment cost is one of the major challenges for patients suffering from diseases such as multiple sclerosis and cancer. High treatment cost restricts the adoption of drugs. which reduces patient adherence and poses a challenge to market growth.

Competitive Landscape

The market appears to be mildly concentrated with the presence of few companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

• Bayer AG
• Biogen
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Merck Sharp & Dohme Corp.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY TYPE

• Comparison by type
• Interferon beta - Market size and forecast 2018-2023
• Interferon alfa - Market size and forecast 2018-2023
• Other interferons - Market size and forecast 2018-2023
• Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• RoW - Market size and forecast 2018-2023
• Key leading countries
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 12: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bayer AG
• Biogen
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Merck Sharp & Dohme Corp.

For more information about this report visit https://www.researchandmarkets.com/research/7b6vwz/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190220005810/en/